According to the latest industry analysis from Future Market Insights, the global venous stents market is witnessing remarkable expansion. Valued at approximately USD 990.5 million in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 8.4%, reaching an impressive USD 2.2 billion by 2033. This growth highlights the rising demand and increasing adoption of venous stents in the medical field.
Several key factors are driving this substantial growth. The global prevalence of venous diseases, coupled with an aging population, has led to a surge in demand for advanced venous stent solutions. Additionally, significant investments in research and development by manufacturers are fostering innovation and leading to the creation of state-of-the-art venous stents. These innovations are propelling the market forward, offering more effective solutions for patients with chronic venous disorders.
Venous diseases, which range from minor changes in reticular veins to severe venous ulcers, affect a large portion of the global population. These conditions can lead to debilitating disabilities, underscoring the critical need for effective therapeutic interventions such as venous stents. The ongoing technological advancements introduced by leading market players are enhancing the efficacy and safety of stent procedures, ultimately improving patient outcomes.
The venous stents market is set to offer promising opportunities for healthcare providers and manufacturers alike. With continuous advancements and the rising prevalence of venous diseases, the importance of venous stents in vascular surgery will continue to grow, solidifying their role as essential medical devices in the treatment of chronic venous disorders.
As the market expands, healthcare providers, industry stakeholders, and manufacturers will have an opportunity to contribute to and benefit from the next wave of innovation in venous stent technology, improving patient care and outcomes across the globe.
Key Takeaways from Market Study:
- Nitinol material held the market share of5% in the global market 2022 because of its benefits over other materials and increasing popularity in treating venous diseases.
- Chronic Deep Vein Thrombosis (DVT) has a market share of 6% in the global market 2022 owed to increasing prevalence of chronic DVT.
- Open cell stent design held 88.1% value share globally in 2022 as it allows for greater flexibility and conformability to the shape of the vein.
- Introducer size no – 09 dominated the global market with value share of 4% in 2022 as it is large enough to accommodate larger stents, necessary in cases where the stenosis (narrowing) in the vein is severe.
- Hospitals held a market share of 9% in the global market 2022 as they employ skilled healthcare professionals, and adoption of advanced technology.
- North American region dominated the global market with U.S. contributing around USD 301.9 Million in 2022 due to increasing technological development and increasing healthcare expenditure.
“Growing geriatric population, use of minimally invasive procedures, rising prevalence of venous disorders, advancements in venous stent development, and government investments in new product development factors are driving the global venous stents market”, says an analyst of Future Market Insights.
Discover the Rising Demand for Venous Stents: Dive into Our Full Report for Detailed Trends and Insights!
Market Competition:
The key players in the market are actively working to improve their positions through product approvals, partnerships, acquisitions, launches, collaborations, and agreements with both existing and up-and-coming market participants. A manufacturer’s chances of capturing a sizable market share are significantly increased by acquisitions and partnerships.
A few examples of strategies acquired by the key players:
- In July 2021, BIOTRONIK obtained Food and Drug Administration USFDA approval for novel peripheral self-expanding stent Pulsar-18 T3. This new, improved stent is beneficial for endovascular treatments.
- In March 2022, Cordis Corporation got USFDA approval for S.M.A.R.T. RADIANZ Vascular Stent System. This novel stent has use on radial peripheral procedures. It allows for the precise, effective implantation of stents in the superficial femoral (SFA) and iliac arteries.
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the venous stents market in its latest study, presenting a historical demand assessment of 2018–2022 and projections for 2023–2033. The venous stents market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Key Companies Profiled:
- Becton, Dickinson and Company
- Cook Group Inc.
- Boston Scientific Corporation
- Medtronic
- Koninklijke Philips N.V. (Vesper Medical Inc.)
- Optimed Medizinische Instrumente GmbH
- plus medica GmbH & Co. KG
- Abbott Laboratories, Inc.
Key Market Segments Covered in the Venous Stents Industry Research:
Material:
- Nitinol
- Elgiloy
Indication:
- Chronic Deep Vein Thrombosis
- Post-Thrombotic Syndrome (PTS)
- May-Thurner’s Syndrome (MTS)
- Pelvic Congestion Syndrome (PCS)
- Others
Stent Design:
- Braided
- Open Cell
- Closed Cell
- Hybrid
Introducer Size:
- Size 6
- Size 7
- Size 8
- Size 9
- Size 10
End User:
- Hospital
- Ambulatory Surgery Centers
- Specialty Clinics
- Cardiac Catheterization Labs
Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Central Asia
- Russia & Belarus
- Balkan & Baltic Countries
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube